logo

For the Inventor, By the Inventor

Oslo, Norway

Vaccibody as


USPTO Granted Patents = 5



Trademarks = 1

Forward Citations = 8

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Bjarne Bogen (4 out of 15 patents)

silverMedal Agnete Brunsvik Fredriksen (4 out of 9 patents)

bronzeMedal Inger Sandlie (3 out of 18 patents)

4.  Pier Adelchi Ruffini (1 out of 3 patents)

5.  Ole Henrik Brekke (1 out of 1 patent)

6.  Ali Areffard (1 out of 1 patent)

7.  Mona Mari Lindeberg (1 out of 1 patent)

8.  Agnete Fredriksen Brunsvik (1 out of 1 patent)


5 patents:

1. 10590195 - Homodimeric protein constructs (2020-03-17),
2. 9901635 - Vaccines against HPV (2018-02-27),
3. 9796787 - Modified antibody (2017-10-24),
4. 9169322 - Modified antibody (2015-10-27),
5. 8932603 - Modified antibody (2015-01-13),
Vaccibody is a biotechnology company focused on the development of novel cancer vaccines. Their proprietary platform technology utilizes virus-like particles and individual tumor antigens to stimulate a potent immune response against cancer cells. Vaccibody's lead product candidate, VB10.NEO, is currently in clinical trials for the treatment of solid tumors.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#92 in Oslo

#311 in Norway

...
Oslo, Norway

Vaccibody as

Forward Citations = 8

8 inventors:

goldMedal Bjarne Bogen (4 out of 15 patents)

silverMedal Agnete Brunsvik Fredriksen (4 out of 9 patents)

bronzeMedal Inger Sandlie (3 out of 18 patents)

4.  Pier Adelchi Ruffini (1 out of 3 patents)

5.  Ole Henrik Brekke (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com
Loading…